Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Origene Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Origene Technologies

Origene Technologies

US-based OriGene provides comprehensive gene-based research solutions including cDNA clones, antibodies, proteins, and more.

HQ
Rockville, MD, US
Founded
1996
Overview
Compare
Fundraising
Employees
Website

Founded in Rockville, United States, OriGene Technologies is dedicated to advancing gene-based research by providing comprehensive solutions such as over 37,000 human full-length ORF cDNA clones, 50,000 primary antibodies, 10,000 human proteins, and various other research reagents. The company's core mission is to support scientific discoveries and innovations in fields like oncology, neuroscience, immunology, and signal transduction through high-quality products and services.

OriGene has garnered attention for its extensive catalog and commitment to quality, attracting notable researchers and institutions globally. The company has achieved significant milestones in the development of custom antibody solutions and CRISPR tools, enhancing the capabilities of laboratories worldwide. OriGene's impact is evident in its contribution to numerous scientific publications and advancements in medical research, solidifying its reputation as a pivotal player in the biotechnology industry.

Origene Technologies - Similar Companies

Origen Therapeutics logo

Origen Therapeutics

Orig3N logo

Orig3N

orig3n.com

ABclonal logo

ABclonal

abclonal.com

Zymo Research logo

Zymo Research

zymoresearch.com

Cyagen Biosciences logo

Cyagen Biosciences

cyagen.com

Epigentek Group logo

Epigentek Group

epigentek.com

Bio-Techne logo

Bio-Techne

Cayman Chemical Company logo

Cayman Chemical Company

Mogene logo

Mogene

mogene.com

Topogen logo

Topogen

topogen.com

Fluidigm logo

Fluidigm

standardbio.com

PackGene Biotech logo

PackGene Biotech

packgene.com

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Intact Genomics logo

Intact Genomics

intactgenomics.com

Viagene logo

Viagene

viagene.com

Origene Technologies - Quick Facts

Who are Origene Technologies' competitors?

Companies similar to Origene Technologies include Origen Therapeutics, Orig3N, ABclonal and Zymo Research.

When was Origene Technologies founded?

Origene Technologies was founded in 1996.

Where is Origene Technologies' headquarters located?

Origene Technologies' headquarters is located in Rockville, MD, US.

When was Origene Technologies' last funding round?

Origene Technologies' most recent funding round was for $17.1M (USD) in June 2015.

How much has Origene Technologies raised to-date?

As of Jun 9, 2015, Origene Technologies has raised a total of $69.4M (USD).

How many employees does Origene Technologies have?

Origene Technologies has 750 employees as of Feb 5, 2024.

Origene Technologies - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Research Reagents
Tags
  • API
  • eCommerce
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified